EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer

Natalija Berza iD, Jana Zodzika iD, Anda Kivite-Urtane, Nicholas Baltzer, Alise Curkste, Ilva Pole, Mari Nygård, Kersti Pärna, Mindaugas Stankunas, Anna Tisler iD, Anneli Uuskula iD

European Journal of Public Health · 2024

DOI: 10.1093/eurpub/ckae075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Public Health, 2024. Verfasst von Natalija Berza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health, Riga Stradins University, Riga, Latvia. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EEA Financial Mechanism Baltic Research Program 2014-2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-risk human papillomavirus (HR-HPV) is a known cause of cervical cancer (CC). Latvia has a high incidence of CC compared with the average incidence in the European Union. This study aims to fill the data gap on the HR-HPV burden in Latvia, providing information on its prevalence and associated factors.

Methods

The cross-sectional study was conducted from February 2021 to April 2022.

Participants

25–70 years old visiting a general practitioner (general population) or those referred to a colposcopy clinic with changes in their cervical cytology (colposcopy population) collected vaginal self-sample and completed a paper-based questionnaire. Samples were analyzed with Cobas 6800 System (Roche) for HPV16, HPV18 and other HR-HPV (HPV31/33/35/39/45/51/52/56/58/59/66/68). Descriptive statistics for categorical variables were performed. The Chi-square test was used to determine for the statistical significance of differences in the proportions of the dependent variable between subgroups of the independent variable. Univariate and multivariate binary logistic regression were used to identify factors associated with positive HR-HPV status. Results were considered statistically significant at P < 0.05.

Results

A total of 1274 participants provided a valid sample. The prevalence of any HR-HPV infection was 66.8% in the colposcopy group and 11.0% in the general population. Factors associated with positive HR-HPV status were marital status single/divorced/widowed (vs. married/cohabiting) [adjusted OR (aOR) 2.6; P = 0.003], higher number of lifetime sex partners [aOR 5.1 (P < 0.001) and 4.0 (P = 0.001)] for six or more and three to five partners in the general population; in the colposcopy group, the statistical significance remained only for Latvian ethnicity (vs. other) (aOR 1.8; P = 0.008) and current smoking (vs. never) (aOR 1.9; P = 0.01).

Conclusion

We documented a comparison to European Union HR-HPV infection burden in Latvia. Any HR-HPV positivity was significantly associated with sexual and other health behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsHumansFemaleMiddle AgedAdultCross-Sectional StudiesPrevalenceAgedLatviaIncidenceRisk FactorsPapillomaviridaeSurveys and QuestionnairesHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Institute of Public Health, Riga Stradins University, Riga, Latvia.
  • Gynaecology Department, Riga East Clinical University Hospital, Riga, Latvia.
  • Department of Public Health and Epidemiology, Riga Stradins University, Riga, Latvia.
  • Cancer Registry of Norway, Oslo, Norway.
  • Laboratory Service, National Microbiology Reference Laboratory, Riga East University Hospital, Riga, Latvia.
  • Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

ORCID-Profile: Natalija Berza, Jana Zodzika, Anna Tisler, Anneli Uuskula

Förderung

  • EEA Financial Mechanism Baltic Research Program 2014-2022

Zitieren

APA

Berza, N., Zodzika, J., Kivite-Urtane, A., Baltzer, N., Curkste, A., Pole, I., Nygård, M., Pärna, K., Stankunas, M., Tisler, A., & Uuskula, A. (2024). Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckae075

Vancouver

Berza N, Zodzika J, Kivite-Urtane A, Baltzer N, Curkste A, Pole I, et al. Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer. European Journal of Public Health. 2024. doi:10.1093/eurpub/ckae075

BibTeX
@article{Berza2024,
  author = {Berza, Natalija and Zodzika, Jana and Kivite-Urtane, Anda and Baltzer, Nicholas and Curkste, Alise and Pole, Ilva and Nygård, Mari and Pärna, Kersti and Stankunas, Mindaugas and Tisler, Anna and Uuskula, Anneli},
  title = {Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer},
  journal = {European Journal of Public Health},
  year = {2024},
  doi = {10.1093/eurpub/ckae075}
}
Kostenlos starten →